课题基金 / 基金详情

Engineering Developmental Microenvironments: Cartilage Formation and Maturation

Engineering Developmental Microenvironments: Cartilage Formation and Maturation
工程发育微环境:软骨的形成和成熟
批准号:
7653444
负责人:
Jason A Burdick
金额:
$34.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-13 至 2013-02-28

项目摘要

项目成果

Jason A Burdick的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):关节软骨排列在关节表面,并传递载荷产生的力。由于软骨自然愈合能力的限制,以及骨关节炎发病率的增加,对基于细胞的修复策略的需求越来越大。组织工程学,尤其是基于自体间充质干细胞(MSCs)的方法,正在发展成为一种促进软骨再生的临床相关技术。然而,用于植入的工程化结构的力学和ECM组织尚未与天然组织相匹配,不足以支持关节负荷。大多数软骨组织工程努力复制软骨发育的早期阶段,以一定的体积隔离高密度的软骨细胞外基质产生细胞。然而,在软骨形成的这些早期快速阶段和使其具有成体功能的逐渐重塑(成熟)之间存在着显著的差异。随着负重的使用,软骨细胞外基质被完全重塑为成人组织的独特成分和结构。这一变革性的过程是由多种时间因素(化学、机械和可溶性)驱动的。我们的软骨组织工程方法采用了这种复杂的发育模式(从胚胎到成人)的概念,并采用了基于天然ECM成分的合成水凝胶,它提供了初始的受体-基质结合、受控的机制和定制的降解特征。这些凝胶,再加上生理负荷和相关可溶性因子的暂时应用,将重新创造发育微环境,从而支持和鼓励MSCs在三维培养中产生功能性软骨。在第一个目标中,MSCs将被包裹在先前作为软骨细胞载体进行研究的HA水凝胶中,该水凝胶具有一系列结构,可以影响细胞的存活、受体结合、扩散以及最终的新生组织特性,并在一系列条件下(即细胞密度和可溶性因子的时间变化)进行培养。在第二个目标中,我们实验室最近开发的新型HA水凝胶将作为3D网络进行研究,以促进MSC的软骨生成和构建成熟。降解的时间变化将通过可降解基团的类型、交联度以及与不含可水解性基团的HA大分子共聚来改变。在第三个目标中,一种将滑动接触应用于水凝胶结构的机械加载生物反应器将应用于AIMS 1和AIMS 2中确定的负载MSC的水凝胶,概括了软骨的正常生理负载模式。机械预适应参数将在短期(基因表达)和长期(基质生产、组织和力学)中进行评估。这些目的是为了测试我们的假设,即控制MSC微环境,并包含正常发育过程中存在的对软骨形成和成熟既允许又有指导作用的信号,将导致最终构建具有类似天然组织特性的结构。公共卫生相关性:该项目开发了一种临床相关的软骨修复方法,使用含有时间控制的结构的MSC水凝胶,经过生理机械条件处理,以模拟从胚胎到成年发生的组织形成和成熟的发育范式。这种生物材料系统提供受体-基质相互作用、受控机制和量身定制的降解曲线,以增强包裹的MSCs的分化和形成的细胞外基质(ECM)的积累和分布。如果成功,这种方法将跨越软骨组织工程学的一个主要障碍,提供更具结构相关性的ECM,具有增强的机械性能,以支持关节中的高强度负荷。这种软骨组织工程技术可以帮助治疗数百万因创伤或疾病而导致的软骨衰弱丢失和退化的患者。
英文摘要
DESCRIPTION (provided by applicant): Articular cartilage lines the surfaces of joints and transmits the forces generated with loading. Due to limitations in cartilage's natural healing capacity, and given the increasing incidence of osteoarthritis, there exists a growing demand for cell-based strategies for repair. Tissue engineering, and particularly those approaches based on autologous mesenchymal stem cells (MSCs), is evolving as a clinically relevant technique to promote cartilage regeneration. Yet, the mechanics and ECM organization of engineered constructs for implantation have yet to match those of the native tissue and are insufficient to support joint loading. Most cartilage tissue engineering efforts replicate early stages of cartilage development, sequestering a high density of cartilaginous ECM producing cells in a defined volume. However, significant differences exist between these early rapid stages of cartilage formation and the gradual remodelling (maturation) that enables its adult function. With load-bearing use, cartilage ECM is wholly remodelled into the unique composition and architecture of the adult tissue. This transformative process is driven by a multitude of temporal factors (chemical, mechanical, and soluble). Our approach to cartilage tissue engineering adopts concepts of this complex developmental paradigm (from embryo to adult) with a synthetic hydrogel based on a natural ECM component, which provides initial receptor-matrix binding, controlled mechanics, and tailored degradation profiles. These gels, coupled with physiologic loading and temporal application of relevant soluble factors will re-create developmental microenvironments that both enable and encourage functional cartilage production by MSCs in 3-D culture. In the first Aim, MSCs will be encapsulated in HA hydrogels previously investigated as chondrocyte carriers with a range of structures that can influence cell viability, receptor-binding, diffusion, and ultimately, neocartilage properties and cultured under a range of conditions (i.e., cellular density and temporal variations in soluble factors). In the second Aim, novel HA hydrogels recently developed in our laboratory that degrade via both hydrolytic and enzymatic mechanisms will be investigated as 3D networks to promote MSC chondrogenesis and construct maturation. Temporal changes in degradation will be altered through the type of degradable group, crosslinking density, and copolymerization with HA macromers without hydrolytically degradable groups. In the third Aim, a mechanical loading bioreactor that applies sliding contact to hydrogel constructs will be applied to MSC-laden hydrogels identified in Aims 1 and 2, recapitulating normal physiologic loading patterns of cartilage. Mechanical preconditioning parameters will be evaluated in the short term (gene expression) and long term (matrix production, organization, and mechanics). These Aims were designed to allow the testing of our hypotheses that control over the MSC microenvironment and inclusion of signals present during normal development that are both permissive and instructive for cartilage formation and maturation will lead to final constructs with properties akin to native tissue. PUBLIC HEALTH RELEVANCE: This project develops a clinically-relevant approach to cartilage repair using MSC-laden hydrogels with temporally controlled structures subjected to physiologic mechanical conditioning to mimic the developmental paradigm of tissue formation and maturation that occurs from the embryo to adulthood. This biomaterial system provides receptor-matrix interactions, controlled mechanics, and tailored degradation profiles to enhance the differentiation of encapsulated MSCs and the accumulation and distribution of formed extracellular matrix (ECM). If successful, this approach would surmount a major hurdle in cartilage tissue engineering to provide a more structurally relevant ECM with enhanced mechanical properties to support the intense loads found in the joint. This cartilage tissue engineering technique could aid in the treatment of millions of patients afflicted with debilitating cartilage loss and degeneration due to trauma or disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered Granular Hydrogels for Endogenous Tissue Repair
  • 批准号:
    10629201
  • 项目类别:
  • 资助金额:
    $55.88万
  • 财政年份:
    2022
  • 负责人:
    Jason A Burdick
  • 依托单位:
Image Guided Delivery of Bioresponsive Hydrogels
  • 批准号:
    10078547
  • 项目类别:
  • 资助金额:
    $78.96万
  • 财政年份:
    2017
  • 负责人:
    Jason A Burdick
  • 依托单位:
2014 Signal Transduction by Engineered Extracellular Matrices Gordon Research Con
  • 批准号:
    8710776
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2014
  • 负责人:
    Jason A Burdick
  • 依托单位:
Localized Targeting of Matrix Proteases Following Myocardial Infarction
海外基金